Humira

The Success Story of Biosimilars

With their triumphant advance, biosimilars are also setting in motion the usual market mechanisms. Biopharma interest groups warn against the automatic substitution of originator drugs.

Injecting Growth and Innovation

Boehringer Wins Europe’s First Biosimilar Approval

Chances and Hurdles for Biosimilars

Leaving the Patent Cliff Behind

AbbVie Wins Shire Prize for Nearly $55 Billion

Shire to Bow to AbbVie's Sweetened $53 Billion Offer

The Biosimilar Market

Court Stops EU Regulator Releasing Drug Company Data

Abbott Results Bode Well for Spun-off AbbVie

Abbott Sticks to 2012 View, Despite Stronger Dollar

The World Of Biosimilars